This guideline provides clinicians with up-to-date evidence-based information regarding the management of endometrial hyperplasia. This is a joint guideline between the RCOG and the British Society for Gynaecological Endoscopy (BSGE).

Diagnosis of endometrial hyperplasia requires histological examination of the endometrial tissue. Endometrial surveillance should include endometrial sampling by outpatient endometrial biopsy. Diagnostic hysteroscopy should be considered to facilitate …

2023年8月17日 · Summary: Endometrial intraepithelial neoplasia (EIN) or atypical endometrial hyperplasia (AEH) often is a precursor lesion to adenocarcinoma of the endometrium. Hysterectomy is the definitive treatment for EIN–AEH.

Management of EH or EIN is reviewed here. Related topics can be found separately: (See "Endometrial hyperplasia or endometrial intraepithelial neoplasia: Clinical features, diagnosis, and differential diagnosis".) (See "Overview of resectable endometrial carcinoma".)

2024年4月30日 · Apply strategies for evaluating endometrial hyperplasia, including the use of appropriate diagnostic tools such as transvaginal ultrasound and endometrial sampling. Select evidence-based treatment modalities for endometrial hyperplasia, differentiating instances in which each would be appropriate.

Presently, cyclic progestin or hysterectomy constitutes the major treatment option for EH without or with atypia, respectively. However, clinical trials of hormonal therapies and definitive standard treatments remain to be established for the management of EH.

2024年1月25日 · Early diagnosis and treatment of EH (with or without atypia) can prevent progression to endometrial carcinoma. Terminology of EH varies widely (table 1). This topic will utilize the 2014 World Health Organization classification criteria [1].

The aim of this guideline is to aid primary care physicians and gynaecologists in the initial evaluation of women with suspected endometrial hyperplasia, to recommend the use of the 2014 World Health Organization classification for endometrial hyperplasia by all health care providers, and to guide the optimal treatment of women diagnosed with ...

This guideline applies to all patients diagnosed with endometrial hyperplasia, and the staff involved in their healthcare. The provision of a dedicated clinic for patients with endometrial hyperplasia ensures that all patients are seen swiftly after diagnosis, achieving equality of access for all, regardless of the route of referral. Ensuring that

In order to facilitate informed choice, patients should be provided with information and support that is evidence-based, culturally appropriate, and tailored to their needs. This guideline was written using language that places women at the centre of care.